Selexis is a privately held biotechnology company. Selexis SA has no securities registered under the United States Securities Act of 1933. Materials contained on this site do not constitute a solicitation, offer or recommendation concerning, or refer in any way to, any sale of securities.
The materials on the site contain forward-looking statements based on a number of assumptions and beliefs in light of the information currently available to management and subject to significant risks and uncertainties. Actual financial results may differ materially depending on a number of factors including, adverse economic conditions, currency exchange rate fluctuations, adverse legislative and regulatory developments, pricing and product initiatives of competitors, the inability of the company to market existing and new products effectively, interruptions in production, infringements of the company's intellectual property rights and the adverse outcome of material litigation.